ARTICLE | Clinical News
AMC303: Ph I/Ib started
November 2, 2016 11:07 PM UTC
amcure began an open-label, dose-escalation, dose-expansion, European Phase I/Ib trial to evaluate AMC303 in up to 50 patients....
BCIQ Company Profiles
BCIQ Target Profiles